We have developed a simple liver micronucleus assay using young rats (up to 4 weeks old) to assess cytogenetic damage of chemicals in liver cells. Diethylnitrosamine (DEN) was used as a model rodent hepatocarcinogen in this study. Compared to the partial hepatectomy method most commonly used for the liver micronucleus assay, the present assay method showed equal or even higher practicability. The young rat liver micronucleus assay was also characterized for rat strain differences, sampling time after treatment, single treatment vs. split treatment, age of animals, administration route, and staining method. Although based on one model chemical, we propose an acceptable protocol for the micronucleus assay using young rat liver as follows: Up to 4-week-old rats should be used; oral or intraperitoneal administration can be used; single or repeated treatment protocols can be applied; sampling time is 3–5 days after the last treatment; hepatocytes are prepared by the collagenase perfusion method; and cells are stained with the AO-DAPI double staining method.   

1.
Angelosanto FA: Tissues other than bone marrow that can be used for cytogenetic analysis. Environ molec Mutagen 25:338–343 (1995).
2.
Braithwaite I, Ashby J: A non-invasive micronucleus assay in the rat liver. Mutat Res 203:23–32 (1988).
3.
Cliet I, Fournier E, Melcion C, Cordier A: In vivo micronucleus test using mouse hepatocytes. Mutat Res 216:321–326 (1989).
4.
Committee on the Mutagenicity of Chemicals: Guidance on a Strategy for Testing Chemicals for Mutagenicity. (London 2000).
5.
Furner RL, Gram TE, Stitzel RE: The influence of age, sex and drug treatment on microsomal drug metabolism in four rat strains. Biochem Pharmacol 18:1635–1641 (1969).
6.
Hayashi M, Morita T, Kodama Y, Sofuni T, Ishidate M Jr: The micronucleus assay with mouse peripheral blood reticulocytes using Acridine Orange coated slides. Mutat Res 245:245–249 (1990).
7.
Higgins GM, Anderson RM: Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12:186–202 (1931).
8.
Imaoka S, Fujita S, Funae Y: Age-dependent expression of cytochrome P-450s in rat liver. Biochim biophys Acta 1097:187–192 (1991).
9.
Grisham JW: A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3. Cancer Res 22:842–849 (1962).
10.
Kastenbaum MA, Bowman KO: Tables for determining the statistical significance of mutation frequencies. Mutat Res 9:527–549 (1970).
11.
Kato R, Yamazoe Y: Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicol Lett 64/65:661–667 (1992).
12.
Mereto E, Brambilla-Campart G, Ghia M, Martelli A, Brambilla G: Cinnamaldehyde-induced micronuclei in rodent liver. Mutat Res 322:1–8 (1994).
13.
Morita T, Asano N, Awogi T, Sasaki Y, Sato S, Shimada H, Sutou S, Suzuki T, Wakata A, Sofuni T, Hayashi M: Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens. Groups 1, 2A and 2B. The summary report of the 6th collaborative study by CSGMT/JEMSMMS. Mutat Res 389:3–122 (1997).
14.
Noguchi T: The development of testis micronucleus test (Abstract). 26th JEMS, Hatano, 92 (1997).
15.
Parton JW, Garriott ML: An evaluation of micronucleus induction in bone marrow and in hepatocytes isolated from collagenase perfused liver or from formalin-fixed liver using four-week-old rats treated with known clastogens. Environ molec Mutagen 29:379–385 (1997).
16.
Rossi AM, Romano M, Zaccaro L, Pulci R, Salmona M: DNA synthesis, mitotic index, drug-metabolising systems and cytogenetic analysis in regenerating rat liver. Mutat Res 182:75–82 (1987).
17.
Roy B, Das RK: Evaluation of genotoxicity of clofazimine, an antileprosy drug, in mice in vivo. II. Micronucleus test in bone marrow and hepatocytes. Mutat Res 241:169–173 (1990).
18.
Sawada S, Yamanaka T, Yamatsu K, Furihata C, Matsushima T: Chromosome aberrations, micronuclei and sister-chromatid exchanges (SCEs) in rat liver induced in vivo by hepatocarcinogens including heterocyclic amines. Mutat Res 251:59–69 (1991).
19.
Sipes IG, Gandolfi AJ: Biotransformation of toxicans, in Amdur MO, Doull J, Klassen CD (eds): Casarett and Doull’s Toxicology, The Basic Science of Poisons, pp 88–126 (McGraw-Hill, New York 1993).
20.
Tates AD, Neuteboom I, Hofker M, Engelse L: A micronucleus technique for detecting clastogenic effects of mutagens/carcinogens (DEN, DMN) in hepatocytes of rat liver in vivo. Mutat Res 74:11–20 (1980).
21.
Zhurkov VS, Sycheva LP, Salamatova O, Vyskubenko IF, Feldt EG, Sherenesheva NI: Selective induction of micronuclei in the rat/mouse colon and liver by 1,2-dimethylhydrazine: a seven-tissue comparative study. Mutat Res 368:115–120 (1996).
© 2003 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.